Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Opicapone as First-line Strategy for the Treatment of Wearing-off in Patients with Parkinson's Disease

              Author:Ferreira, Joaquim   Lee, Jee-Young   Ma, Hyeo-il   Jeon, Beomseok   Poewe, Werner   Antonini, Angelo   Stocchi, Fabrizio   Rodrigues, Daniela   Fisher, Stanley   Fonseca, Miguel   Rocha, José-Francisco   Castilla-Fernández, Guillermo   Holenz, Joerg   Rascol, Olivier   

              Session Name:P7: Movement Disorders: Parkinson's Disease Management  

              Topic:Movement Disorders  

              Program Number:P7.026  

              Author Institution:IMM Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa  CNS-Campus Neurológico, Instituto De Medicin, Portugal  Department of Neurology, Seoul National University Hospital, Seoul, Korea, Republic of  Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria  University San Raffaele Roma and Institute for Research and Medical Care IRCCS San Raffaele, Rome, Italy  Amneal Pharmaceuticals, Warren, NJ  Clinical Investigation Centre CIC1436 Departments of Neurosciences and Clinical Pharmacology, Centre of Excellence for Neurodegeneration COEN NeuroToul, and NS-Park/FCRIN network  University of Toulouse 3, University Hospital of Toulouse, INSERM, Toulouse, France  

              Long-term Follow-up of Opicapone Use as Add-on to Levodopa in Parkinson’s Patients Without Motor Fluctuations: Findings from the EPSILON Study

              Author:Ferreira, Joaquim   Rascol, Olivier   Stocchi, Fabrizio   Antonini, Angelo   Lapuente, Paloma   Castilla-Fernández, Guillermo   Brigas, Helena   Banisadr, Ghazal   Rocha, José-Francisco   Holenz, Joerg   Poewe, Werner   

              Session Name:P7: Movement Disorders: Parkinson's Disease Management  

              Topic:Movement Disorders  

              Program Number:P7.027  

              Author Institution:IMM Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa  CNS-Campus Neurológico, Instituto De Medicin, Portugal  Clinical Investigation Centre CIC1436 Departments of Neurosciences and Clinical Pharmacology, Centre of Excellence for Neurodegeneration COEN NeuroToul, and NS-Park/FCRIN network  University of Toulouse 3, University Hospital of Toulouse, INSERM, Toulouse, France  University San Raffaele Roma and Institute for Research and Medical Care IRCCS, Rome, Italy  BIAL – Portela & Ca S.A., CORONADO (S. Romão E S. Mamede, Portugal  Amneal Pharmaceuticals, Evanston, IL  Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria